CL Educate Limited has informed the Exchange regarding 'Disclosure of non-Debarment from holding office of Director for Dr. Abhay Jere '.
CLEDUCATE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CL Educate has confirmed that Dr. Abhay Jere, recently appointed as Managing Director and CEO of its material unlisted subsidiary DEXIT Global Limited (formerly NSEIT Limited), has not been debarred from holding the office of Director by SEBI or any other regulatory authority. This disclosure is a follow-up to the company's earlier filing dated February 28, 2026, regarding Dr. Jere's appointment as an Additional Director (Non-Independent, Executive Director) and Key Managerial Personnel on the subsidiary's board. The confirmation is being made to comply with BSE Circular LIST/COMP/14/2018-19 and NSE Circular NSE/CML/2018/24 dated June 20, 2018. The filing was signed by Rachna Sharma, Company Secretary, from New Delhi on March 11, 2026.
This is a routine regulatory compliance disclosure and not a material business event. It simply clears any uncertainty about the eligibility of the new subsidiary MD & CEO, with no negative regulatory findings, so shareholders are unlikely to see any stock price impact from this filing.